The primary pathophysiological factors underlying MASLD are metabolic dysfunction and atherogenic dyslipidemia [45]
While gastrointestinal AEs such as nausea and vomiting dominate safety reports 8 and recent pharmacovigilance studies highlight increasingly recognized risks including acute pancreatitis, nephritis, hypotension, and syncope 9,10,11 , emerging data suggest that GLP-1 RAs may be associated with neurological adverse events (NAEs) 12,13
She had completed her family and was also considering breast surgery
AstraZeneca's commercial obesity heritage is cotadutide (GLP-1/glucagon dual, divested) and its longer-term diabetes franchise (dapagliflozin and its combinations)
Ipamorelin is a pentapeptide that acts as a growth hormone secretagogue
For context, semaglutide (Ozempic) went through Phase III trials involving thousands of patients across multiple countries before approval